US12227781B2 - Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles - Google Patents
Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles Download PDFInfo
- Publication number
- US12227781B2 US12227781B2 US16/880,917 US202016880917A US12227781B2 US 12227781 B2 US12227781 B2 US 12227781B2 US 202016880917 A US202016880917 A US 202016880917A US 12227781 B2 US12227781 B2 US 12227781B2
- Authority
- US
- United States
- Prior art keywords
- nanoparticles
- photothermal
- reaction mixture
- photothermal nanoparticles
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 253
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 52
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 49
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 28
- 230000003321 amplification Effects 0.000 title claims abstract description 27
- 239000011541 reaction mixture Substances 0.000 claims abstract description 56
- 239000000203 mixture Substances 0.000 claims abstract description 50
- 238000010438 heat treatment Methods 0.000 claims abstract description 38
- 102000004190 Enzymes Human genes 0.000 claims abstract description 8
- 108090000790 Enzymes Proteins 0.000 claims abstract description 8
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims abstract description 4
- 238000013518 transcription Methods 0.000 claims abstract description 3
- 230000035897 transcription Effects 0.000 claims abstract description 3
- 238000003752 polymerase chain reaction Methods 0.000 claims description 87
- 238000006243 chemical reaction Methods 0.000 claims description 56
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 30
- 238000000576 coating method Methods 0.000 claims description 21
- 239000010931 gold Substances 0.000 claims description 21
- 239000002091 nanocage Substances 0.000 claims description 20
- 229910052737 gold Inorganic materials 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 16
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 12
- 229910052751 metal Inorganic materials 0.000 claims description 12
- 239000002184 metal Substances 0.000 claims description 11
- 229910045601 alloy Inorganic materials 0.000 claims description 10
- 239000000956 alloy Substances 0.000 claims description 10
- 150000002739 metals Chemical class 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000010949 copper Substances 0.000 claims description 8
- 239000011258 core-shell material Substances 0.000 claims description 7
- 230000001678 irradiating effect Effects 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229910052697 platinum Inorganic materials 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 229910052709 silver Inorganic materials 0.000 claims description 5
- 239000004332 silver Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 229910052763 palladium Inorganic materials 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 229920001059 synthetic polymer Polymers 0.000 claims description 4
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 230000003100 immobilizing effect Effects 0.000 claims 1
- 210000000887 face Anatomy 0.000 description 61
- 108020004414 DNA Proteins 0.000 description 17
- 102000053602 DNA Human genes 0.000 description 17
- 239000002077 nanosphere Substances 0.000 description 12
- 239000002245 particle Substances 0.000 description 11
- 230000000692 anti-sense effect Effects 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 230000001351 cycling effect Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- -1 but not limited to Chemical class 0.000 description 9
- 230000000295 complement effect Effects 0.000 description 9
- 230000005284 excitation Effects 0.000 description 9
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 8
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 8
- 238000000137 annealing Methods 0.000 description 8
- 238000004925 denaturation Methods 0.000 description 8
- 230000036425 denaturation Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 108091081021 Sense strand Proteins 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 229920002401 polyacrylamide Polymers 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000003917 TEM image Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 239000002063 nanoring Substances 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000001226 triphosphate Substances 0.000 description 3
- 235000011178 triphosphate Nutrition 0.000 description 3
- 229910001316 Ag alloy Inorganic materials 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 101710103106 Guanine nucleotide-binding protein subunit beta-2-like 1 Proteins 0.000 description 2
- 102100025234 Receptor of activated protein C kinase 1 Human genes 0.000 description 2
- 101710089526 Receptor of activated protein C kinase 1 Proteins 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-N dCTP Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 238000007481 next generation sequencing Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005382 thermal cycling Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 1
- 241000735235 Ligustrum vulgare Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 230000005679 Peltier effect Effects 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000007849 hot-start PCR Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000002055 nanoplate Substances 0.000 description 1
- 239000002073 nanorod Substances 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002342 ribonucleoside Substances 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000003396 thiol group Chemical class [H]S* 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/30—Characterised by physical treatment
- C12Q2523/313—Irradiation, e.g. UV irradiation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/155—Particles of a defined size, e.g. nanoparticles
Definitions
- Described herein are methods of using nanoparticles as a heating media in a polymerase chain reaction (PCR) mixture, which can be heated at a rate up to 75 degrees Celsius/second to complete amplification thermal cycles in less than 15 minutes.
- a typical PCR can take up to few hours to complete depending on the quality and concentration of the target nucleic acid. This slow cycle time cannot meet the demand of many current genetic amplification applications. Therefore, various aspects of embodiments herein are directed to rapid nucleic acid amplification using nanoparticles as a heating media to speed up cycling in PCR.
- plasmonic nanoparticles that absorb energy from light (e.g., from a light emitting diode or laser) and convert it to heat, thereby becoming photothermal nanoparticles.
- the photothermal nanoparticles described in the present invention have a variety of geometric shapes that have been derived to meet extinction peak wavelengths ranging from about 300 nanometers (nm) to 1500 nm. These photothermal nanoparticles can be used as a heat media in PCR mixtures to provide faster heat cycles, and thereby faster PCR cycle times (e.g., less than 15 minutes (min) for 30 cycles or more) that will dramatically increase the workflow efficiency in PCR-based technologies.
- FIGS. 1 A and 1 B illustrate a diagram of a photothermal testing system to evaluate the nanoparticles photo-to-heat conversion for rapid nucleic acid amplification in accordance with the present disclosure
- FIGS. 2 A- 2 U illustrate example photothermal nanoparticles in accordance with the present disclosure
- FIG. 3 A illustrates example photothermal cycles of silver nanoprisms coated with polyvinylpyrrolidone in accordance with the present disclosure
- FIG. 3 B illustrates an example transmission electron microscope (TEM) image of silver nanoprisms in accordance with the present disclosure
- FIG. 3 C illustrates example photothermal cycles of gold nanostars coated with polyethylene glycol in accordance with the present disclosure
- FIG. 3 D illustrates an example TEM image of gold nanostars in accordance with the present disclosure
- FIG. 3 E illustrates example photothermal cycles of gold nanostars coated with polyethylene glycol in accordance with the present disclosure
- FIG. 3 F illustrates an example TEM image of gold nanostars in accordance with the present disclosure
- FIG. 3 G illustrates an example ultraviolet-visible spectrum showing the maximum light absorbance peak of gold nanostars and silver nanoprisms in accordance with the present disclosure.
- FIGS. 4 A and 4 B illustrate gel electrophoresis results from rapid nucleic acid amplification using photothermal gold nanocages in accordance with the present disclosure.
- FIG. 5 illustrates gel electrophoresis results from rapid nucleic acid amplification using photothermal nanocages in accordance with the present disclosure.
- Nanoparticles having a particular geometric shape can be selected for their photothermal profile such that nucleic acid amplification can be rapidly performed.
- collective oscillation of electrons on the nanoparticle surface cause a phenomenon called surface plasmon resonance.
- the particular wavelength of light where this occurs is dependent on the nanoparticle size, shape, and composition.
- nanoparticles having a particular geometry e.g., shape and/or size
- having a particular composition and/or surface coating can be selected to have a maximum peak extinction wavelength ranging from 300 nm to 1500 nm enabling photon to heat conversion for polymerase chain reaction (PCR).
- PCR polymerase chain reaction
- aspects of the present disclosure have been shown to be beneficial in the context of amplifying nucleic acids using PCR with plasmonic, photothermal nanoparticles used as a heating media to increase the heating cycle of the PCR reactions. While not necessarily so limited, various aspects may be appreciated through the following discussion of non-limiting examples which use exemplary contexts.
- PCR is a method widely used in molecular biology to make many copies of a nucleic acid segment. Using PCR, a single copy (or more) of a nucleic acid sequence is exponentially amplified to generate thousands to millions or more copies of that particular nucleic acid segment. The vast majority of PCR methods rely on thermal cycling. Thermal cycling exposes reactants to repeated cycles of heating and cooling to permit different temperature-dependent reactions to occur.
- a typical PCR reaction can take up to a few hours to complete depending on the quality and concentration of the target nucleic acid. This cycle time cannot meet the demand of many, current genetic amplification applications. Faster PCR cycle times (for example, less than 15 minutes (min) for 30 cycles) can increase the workflow efficiency in PCR-based technologies, and hence the downstream applications such as next generation sequencing (NGS). Consistent with various examples of the present disclosure, plasmonic photothermal nanoparticles are used as heating media to speed up the heating cycle of PCR.
- a number of embodiments of the present disclosure are directed to plasmonic photothermal nanoparticles of a variety of different shapes and/or different shape combinations for use as a heating media for PCR-based reaction mixtures.
- These nanoparticles absorb energy from a light source such as lasers or light emitting diode (LEDs) with a wavelength of about 300 nm to 1500 nm and convert the light to heat and to heat a PCR mixture rapidly at a rate up to 75 degrees C./second.
- the nanoparticles heat a PCR mixture rapidly at a rate of up to 40 degrees C./second.
- the nanoparticles heat a PCR mixture rapidly at a rate of up to 20 degrees C./second.
- the nanoparticles heat a PCR mixture rapidly at a rate of up to 10 degrees C./second. These nanoparticles are also stable under light irradiation and have high photo-to-thermal conversion efficiency.
- the photothermal nanoparticles described herein may be composed of metals or alloys with or without inorganic or organic surface coating.
- the nanoparticles may be composed of metals including, but not limited to, gold (Au), silver (Ag), platinum (Pt), palladium (Pd), iron (Fe), copper (Cu), aluminum (Al), zinc (Zn), and combinations thereof with or without an alloy.
- the plasmonic photothermal nanoparticles described herein have a particular geometry and/or shape that is non-spherical and/or non-rod shaped.
- the nanoparticles can have a shape (e.g., geometry) including, but not limited to the following: nanostar, nanotriangle/prism, nanohexapod, hexagonal rings, nanocube, nanoring, nanocage, nanosquare plate, trisoctahedra, rhombicadodecadra, truncated ditetragonal prism, tetrahexahedra, octahedra, decahedra, icosahedra, nanobar, hexagonal plates, rice-like shapes, disk, and combinations thereof.
- the photothermal nanoparticles described in the present invention may also be coated with an organic or inorganic material(s) to prevent interference by PCR-based reaction components due to a bare particle surface and/or enhancement of the stability of the nanoparticle under irradiation and during storage.
- These coating materials include, but are not limited to, silica, synthetic polymers (such as polyvinylpyrrolidone(PVP), thiol terminated Polystyrene, polyacrylamide), oligo or polyethylene glycol, peptides, polysaccharides, non-polymeric coatings, etc.
- the photothermal nanoparticles may be coated with gold and/or coated with a gold-silver alloy.
- Such photothermal nanoparticles may have a particular geometry and a particular chemical coating sufficient to maintain stability under irradiation and to maintain a high photo-to-thermal conversion efficiency.
- the light source can be a laser or LED, with the requirement being that the input power is sufficient for rapid heating ramp at a rate up to 75 degrees C./s.
- the described geometries, shapes, and/or surface coatings of the nanoparticles can provide higher photo-to-thermal conversion efficiency as well as higher shape stability during irradiation, thereby preventing nanoparticle melting during irradiation by the light source.
- Photothermal nanoparticles absorb energy from light, such as a light emitting diode (LED), and convert it to heat.
- a PCR mixture with nanoparticles can be heated at a rate up to 75 degrees Celsius (C) per second to complete 30 or more cycles in 15 min or less time by adjusting the concentration of photothermal nanoparticles.
- the nanoparticles heat a PCR mixture at a rate of up to 40 degrees C./second.
- the nanoparticles heat a PCR mixture rapidly at a rate of up to 20 degrees C./second.
- the nanoparticles heat a PCR mixture rapidly at a rate of up to 10 degrees C./second.
- these photothermal nanoparticles can be tuned to have a variety of peak wavelengths ranging from 300 nm to 1500 nm by adjusting the composition and shape of the nanoparticle. This also enables not only the end-point PCR-based applications, but also real-time PCR-based applications with fluorescent dyes present in the reaction mixture.
- PCR is a temperature-mediated process that requires cycling between set temperatures.
- Single-strand nucleic acids are required for two primer sequences to bind upstream and downstream of the region to be amplified.
- a first step is denaturation or separation of the two strands at around 94-98 degrees C.
- Primer annealing occurs around 45-55 degrees C. and allows the thermo-stable polymerase to bind to defined regions of double stranded deoxyribonucleic acid (DNA).
- a next stage is elongation of the double stranded copy where the temperature is raised to the optimum temperature (around 72 degrees C.) for the enzyme catalysis to proceed.
- temperature is returned to 94 degrees C. for denaturation to single-stranded DNA that allows the cycle to repeat.
- the PCR process can additionally include cooling steps.
- thermocycling of a PCR process can be dependent upon several factors, including the experimentalist's requirements. Additional time to complete PCR is a function of the time to reach the desired temperatures for the temperature-mediated processes (e.g., denaturation, primer annealing, and elongation/synthesis). Shortening ramp and cooling times results in more rapid transition and shorter cycling times.
- PCR is carried out in a reaction volume.
- the reaction volume/mixture contains one nucleic acid to be amplified, which is termed “the original” or “sense” strand.
- the sense strand can be in a double-strand form with its complementary strand, which is termed “the complement” or “antisense” strand. If the sense and antisense strands are present as a double-strand DNA molecule, this double-strand DNA molecule is denatured in a first step of PCR, i.e., the double-strand DNA molecule is split into two single strands, e.g., the sense and antisense strands.
- a double-stranded molecule e.g., DNA or RNA
- the reaction volume/mixture further contains at least two primers.
- “Primers” refer to or include short single-strand nucleic acid segments, which are also known as oligonucleotides, which are a complementary sequence to the target nucleic acid sequence.
- One of the primers is termed a forward primer while the other is termed a reverse primer.
- the forward primer is complementary to the 3′-end of the sense strand.
- the reverse primer is complementary to the 3′-end of the antisense strand.
- the temperature is lowered, and the primers hybridize/bind to their complementary sequences on the nucleic acid sequence.
- the two, now double-stranded, nucleic acid strands then become templates for an enzymatic reaction using a polymerase to transcribe a new nucleic acid strand from free nucleotides that are also found in the reaction volume/mixture.
- the forward primer hybridizes to a sequence in the sense strand while the reverse primer hybridizes to a sequence in the antisense strand.
- the hybridization of the primers with the complementary sequences of the sense strand or antisense strand is termed annealing.
- This second step takes place at a temperature termed the annealing temperature.
- the reaction volume/mixture further contains a DNA polymerase.
- the DNA polymerase synthesizes a copy of the complement starting from the forward primer and synthesizes a copy of the sense strand starting from the 5′ end of the reverse primer.
- the copy of the antisense strand also hybridizes with the sense strand and the copy of the sense strand hybridizes with the antisense strand.
- This third step is termed elongation and is carried out at a temperature called the elongation temperature.
- the first, second, and third steps are repeated until the desired extent of amplification is achieved, wherein multiple copies of the sense and antisense strands are made.
- the nucleic acid generated is itself used as a template for replication, setting in motion a chain reaction in which the original nucleic acid template is exponentially amplified.
- PCR is commonly carried out in a volume of 10-200 microliters ( ⁇ L) in small reaction tubes (e.g., 0.2-0.5 milliliter (mL) volumes) in a thermal cycler.
- the thermal cycler also known as a Thermocycler, PCR Machine, or DNA Amplifier
- Thermal cyclers are typically provided with a thermal block with holes where tubes holding the PCR reaction volumes/mixtures can be inserted. Heat is provided through solid state heaters or infrared lamps. The thermal cycler raises and lowers the temperature of the thermal block in discrete, preprogrammed steps.
- the thermal cycler heats and cools the reaction tubes to achieve the temperatures required at each step (e.g., cycle) of the reaction.
- Many modern thermal cyclers make use of the Peltier effect, which permits both heating and cooling of the block holding the PCR tubes by reversing the electric current.
- Thin-walled reaction tubes permit thermal conductivity to allow for rapid thermal equilibration.
- the reaction volume/mixture further includes a heating media including photothermal nanoparticles that can locally and rapidly heat a reaction volume/mixture to target temperatures to expedite the PCR cycling time.
- the denaturing temperature is chosen such that the single strands of the nucleic acid denature while not effecting, e.g., damaging, the polymerase.
- a typical denaturing temperature is about 95 degrees C.
- the optimal annealing temperature usually depends on the sequence and length of the primers. Typically, primers are designed for an annealing temperature between about 50 degrees C. and 65 degrees C.
- the optimal elongation temperature typically depends on the DNA polymerase used. For example, if using Taq DNA polymerase, an elongation temperature of about 72 degrees C. is commonly used. After elongation, the temperature is returned to 94 degrees C. for denaturation of the double-stranded DNA to single-stranded DNA. This cycling from denaturation-annealing-elongation is repeated a number of times, typically 20 to 40 cycles.
- a nucleic acid template such as a DNA template (e.g., double-stranded DNA) that contains the target sequence to be amplified
- an enzyme that polymerizes new nucleic acid strands e.g., a polymerase enzyme such as DNA polymerase, e.g., Taq DNA polymerase
- two nucleic acid primers oligonucleotides, e.g., single-stranded
- NTPs nucleoside triphosphates
- dNTPs deoxyribonucleotide triphosphates
- rNTPs ribonucleoside triphosphates
- buffer solution providing a suitable chemical environment for amplification and optimum activity and stability of the polymerase.
- the reaction mixture can further include a heating media including photothermal nanoparticles having a particular geometry that allow for rapid heating of the reaction mixture. The addition of a heating media provides a drastic reduction in the time needed for PCR cycling.
- the method of nucleic acid amplification generally includes the steps of contacting the reaction volume/mixture containing a nucleic acid template with photothermal nanoparticles and irradiating the nanoparticles using an activation light source such that the reaction volume/mixture reaches a desired temperature. Accordingly, instead of using Peltier heaters or infrared lamps to transfer heat to the vessel containing the reaction mixture, the reaction of the present disclosure is heated to the desired temperature for the PCR using the photothermal nanoparticles to heat the reaction volume/mixture. In various examples, the whole reaction mixture, half the reaction mixture, less than half the reaction mixture, or a small amount of the reaction mixture around nanoparticles are irradiated.
- the method includes forming a reaction mixture including a nucleic acid template, a polymerase enzyme, and photothermal nanoparticles either suspended in the solution or immobilized on a microchip or on the surface of a well of a substrate such as a multi-well plate.
- the photothermal nanoparticles can be nanoparticles having a particular geometric shape and comprising a single component or multi-components.
- the plurality of plasmonic photothermal nanoparticles can have a resonance wavelength in a particular range to convert energy absorbed from a light source to sufficiently heat a volume of the composition for the transcription of the new nucleic acid strand.
- the particular geometric shape can be selected from the group consisting of: polyhedral, spheroid, torus shapes, among other shapes.
- the particular geometric shape can include a polyhedral nanoparticle.
- the polyhedral nanoparticle can be non-symmetrical.
- the nanoparticle can have a plurality of faces, where at least two of the plurality of faces have a different shape or size as compared to a remainder of the plurality of faces.
- the particular geometric shape can be a polyhedral nanoparticle having a plurality of faces, where at least three of the plurality of faces have a different shape or size as compared to a remainder of the plurality of faces.
- the mixture including the plurality of plasmonic photothermal nanoparticles can include different types of polyhedral shapes.
- the mixture can include a relative ratio of a first type of plasmonic photothermal nanoparticle and a second type of plasmonic photothermal nanoparticle to target a particular peak resonance wavelength.
- the excitation of the photothermal nanoparticles takes place by means of an alternating field such as by an alternating electromagnetic and/or optical field.
- the excitation of the photothermal nanoparticles occurs in the range of ultraviolet light around 300 nm, visible light (e.g., in a range of 400 nm to 700 nm) to the infrared range 710 nm to 1000 nm and radio waves more than 1000 nm.
- excitation of the photothermal nanoparticles occurs in the range of about 300 nm to 1500 nm.
- the wavelength of light at which peak excitation is achieved is dependent upon the geometry of the photothermal nanoparticles used in the reaction mixture/volume.
- the photothermal nanoparticles can be tuned/derived to have a variety of peak wavelengths ranging from about 300 nm to 1500 nm.
- the photothermal nanoparticles can also be tuned/derived to have a variety of peak wavelengths by adjusting the geometry of the particle shape.
- the nanoparticles can be non-spherical and/or non-rod shaped.
- non-spherical and/or non-rod shaped nanoparticles have the following geometries as described in the non-limiting examples of: nanostar, nanotriangle/prism, nanocube, hexagonal, triangular and spherical nanoring, nanocage, nanosquare plate, trisoctahedra, rhombicadodecadra, truncated ditetragonal prism, tetrahexahedra, octahedra, decahedra, icosahedra, nanobar, and rice-like shapes.
- the reaction mixture/volume can include plasmonic, photothermal nanoparticles having a single geometric shape. Additionally and/or alternatively, the reaction mixture/volume can include a combination of nanoparticle geometries. As an illustration, a reaction mixture/volume can comprise nanoparticles having a nanostar geometry, and/or a reaction mixture can comprise nanoparticles having a nanostar geometry and nanoparticles having an octahedral geometry (as non-limiting examples).
- the particular geometry of the nanoparticles, as well as the combination of the nanoparticles can be selected to achieve a particular peak absorption wavelength. For instance, a particular combination of nanoparticle geometries can be selected (e.g., used for the PCR) in order to achieve a particular peak wavelength such as in the range from about 300 nm to 1500 nm.
- the nanoparticles are excited by a laser. More preferably, the laser light has a frequency that excites the surface plasmon resonance of the nanoparticles.
- the laser can supply the light continuously or as pulsed light.
- the laser can be a gas laser, a diode laser, or a diode-pumped solid-state laser, among other types of lasers.
- the nanoparticles and/or the PCR mixture can be irradiated for around ten seconds, or otherwise a sufficient time for increasing the temperature from 45 degrees C. to 95 degrees C.
- the energy of the radiation source (e.g., laser) is transferred to the photothermal nanoparticles due to the absorption of electromagnetic waves by the photothermal nanoparticles.
- the radiation source which is used for the excitation of the nanoparticles, can also originate from sources such as a LED, a thermic radiator, a flash bulb, and/or by ultrasound.
- thermal energy is transferred from the excited nanoparticles to the surrounding reaction mixture/volume such that the temperature of the reaction mixture/volume is sufficient to denature the double-stranded nucleic acids in the reaction mixture/volume.
- rapid PCR cycling times can be produced quickly (e.g., at up to 75 degrees C./second) through the excitation of the nanoparticles to carry out denaturation.
- the annealing and elongation temperatures can also be more rapidly achieved through the excitation of the nanoparticles because only a small amount of energy has to be transferred to excite the nanoparticles.
- the excitation of the nanoparticles then heats the reaction volume (e.g., whole reaction volume, half reaction volume, less than half reaction volume, a small amount of reaction volume, etc.).
- the reaction volume e.g., whole reaction volume, half reaction volume, less than half reaction volume, a small amount of reaction volume, etc.
- the PCR reaction mixture/volume can be heated at up to 75 degrees C./second to complete 30 or more cycles in less than 15 minutes.
- photothermal nanoparticles may be used to heat the reaction mixture/volume.
- the particular geometric shapes of the nanoparticles, as well as the chemical composition of the same, provide photothermal nanoparticles that are stable under light irradiation and have high photo-to-thermal conversion efficiency.
- the geometry of the photothermal nanoparticles are non-spherical and/or non-rod shaped.
- the geometry of the photothermal nanoparticles can be selected from among the following shapes: nanostar, nanotriangle/prism, nanocube, nanoring, nanocage, nanosquare plate, trisoctahedra, rhombicadodecadra, truncated ditetragonal prism, tetrahexahedra, octahedra, decahedra, icosahedra, nanobar, and rice-like shapes.
- the shapes of the nanoparticles can be defined in groups and/or categories.
- One group includes or refers to shapes having single component polyhedral nanoparticles and the other group includes or refers to shapes having multi-component (hybrid) polyhedral nanoparticles.
- the single component polyhedral nanoparticles group includes sub-groups or sub-categories such as polyhedral shapes/nanoparticles (e.g., cubes, prisms, octahedrons, and/or platonic shapes) and polyhedron frames/hollow polyhedrons (e.g., rings, cubic cages, and hollow structures).
- the multi-component group includes sub-groups or sub-categories such as alloys, core-shell shapes, and multi-shell shapes.
- the nanoparticles described are composed of noble metals.
- the nanoparticles can also be composed of metals with an inorganic surface coating. Additionally and/or alternatively, the nanoparticles can be composed of alloys, core-shells, and multi-shells. Examples of such metals and/or alloys include, but are not limited to, gold (Au), silver (Ag), platinum (Pt), palladium (Pd), iron (Fe), copper (Cu), aluminum (Al), zinc (Zn), and/or combinations thereof.
- Alloys can be coated with an organic or inorganic surface coating.
- the nanoparticles can be coated with an organic and/or inorganic surface coating to prevent interference of PCR-based reactions due to a bare particle surface and/or to enhance the stability of the nanoparticle under irradiation and during storage.
- Non-limiting examples of coating materials include: silica, silicon, synthetic polymers (such as PVP, thiol-terminated Polystyrene, polyacrylamide, etc.), oligo or polyethylene glycol, peptides, polysaccharides, etc. Examples are not so limited, and in various embodiments, the coating includes non-polymeric materials.
- plasmonic photothermal nanoparticles of a variety of different shapes and/or different shape combinations are designed and prepared for use as a heating media for PCR-based reaction mixtures.
- These nanoparticles absorb energy from a light source such as lasers or LEDs with wavelength reactions from about 300 nm to about 1500 nm and convert it to heat to heat up a PCR mixture rapidly, at up to 75 degrees C./second.
- These nanoparticles are also stable under light irradiation and have high photo-to-thermal conversion efficiency.
- the photothermal nanoparticles described herein can be composed of metals or alloys with or without inorganic or organic surface coatings.
- the shape and/or geometry of the photothermal nanoparticles impacts photo-to-thermal conversion efficiency and stability under laser irradiation or during storage as well as to determine peak wavelength.
- the photothermal nanoparticles may be composed of metals including, but not limited to, gold (Au), silver (Ag), platinum (Pt), palladium (Pd), iron (Fe), copper (Cu), aluminum (Al), zinc (Zn), and combinations thereof.
- the nanoparticles are made essentially of gold or a gold-silver alloy.
- the geometry of the photothermal nanoparticles described herein are non-spherical and/or non-rod shaped including, but not limited to, nanostar, nanotriangle/prism, nanocube, nanoring, nanocage, nanosquare plate, trisoctahedra, rhombicadodecadra, truncated ditetragonal prism, tetrahexahedra, octahedra, decahedra, icosahedra, nanobar, rice-like shapes, and combinations thereof.
- the absorption peak wavelength of the nanoparticles can be tuned from about 300 nm up to about 1500 nm.
- the photothermal nanoparticles described in the present invention may also be coated with an organic or inorganic material(s) to prevent interference by PCR-based reaction components due to a bare particle surface and/or enhancement of the stability of the nanoparticle under irradiation and during storage.
- These coating materials include, but are not limit to, silica, silicon, synthetic polymers (such as PVP, thiol-terminated Polystyrene, polyacrylamide, etc.), oligo or polyethylene glycol, peptides, polysaccharides, and/or non-polymeric coatings, among others.
- the light source can be a laser or LED with the requirement being that the input power should be enough for rapid heating ramp at up to 75 degrees C./s.
- the photothermal nanoparticles have a very different geometry including shapes that allow for modifying the nanoparticle's peak wavelength from about 300 nm to 1500 nm to enable application in quantitative PCR (qPCR).
- qPCR quantitative PCR
- FIGS. 1 A and 1 B illustrate a diagram of a photothermal testing system to evaluate the nanoparticles photo-to-heat conversion for rapid nucleic acid amplification, in accordance with the present disclosure.
- the system includes a light source 101 , a PCR tube 103 , a thermocouple 105 , and a fan 109 .
- the system includes a PCR tube 103 for receiving the reaction mixture comprising the photothermal nanoparticles.
- the PCR tube 103 can include a container, a chamber, an assembly, or other structure adapted to receive the reaction mixture and nanoparticles and provide optical access thereto.
- a thermocouple 105 can be used to measure the temperature change in the PCR tube 103 containing the photothermal nanoparticles.
- the system further includes a light source 101 for irradiating the photothermal nanoparticles using an activation light beam such that the photothermal nanoparticles release heat sufficient to heat the surrounding reaction mixture.
- the light source 101 can be embodied by a laser or LED (light-emitting diode) generating light at a wavelength coordinated with the plasmonic properties of the nanoparticles.
- the light source 101 can be a laser having the following specifications: an output wavelength of 808 nanometers (nm); output power of 2 watts (W); a divergence angle of 0.1 milliradian (mrad) to around 10 mrad adjustable; a rectangular laser shape; an exit pupil diameter of 5 millimeters (mm); an infrared optical aspheric glass lens optical system; a> ⁇ 2 mm adjustable spot description; a working voltage of 3 volts (V) direct current; an operating current of 1.1 amps (A); a working temperature from ⁇ 10 degrees C. to around 50 degrees C.; a storage temperature of ⁇ 40 degrees C.
- the light source 101 can be part of a light generating assembly allowing a control of optical parameters of the activation light beam such as the wavelength, optical power, and duty cycle in embodiments where the light beam is pulsed, spot size, etc.
- the photothermal nanoparticle is characterized by photothermal properties sufficient for increasing a temperature of a mixture in contact with the photothermal nanoparticle.
- the photothermal nanoparticle may be characterized by photothermal properties sufficient for increasing a temperature of the mixture from 55 degrees C. to 95 degrees C. within 1 second.
- the photothermal nanoparticle may be characterized by photothermal properties sufficient for increasing a temperature of the mixture from 55 degrees C. to 95 degrees C. within 2 seconds.
- the photothermal nanoparticle may be characterized by photothermal properties sufficient for increasing a temperature of the mixture from 55 degrees C. to 95 degrees C. within 4 seconds.
- the photothermal nanoparticle may be characterized by photothermal properties sufficient for increasing a temperature of a mixture in contact with the photothermal nanoparticle at a rate of up to 75 degrees C. per second, at a rate of up to 40 degrees C. per second, at a rate of up to 20 degrees C. per second, and/or at a rate of up to 10 degrees C. per second.
- photothermal properties refer to or include a shape, size, composition, and/or shell structure of the photothermal nanoparticle. For instance, as discussed with regards to FIGS. 2 A- 2 U , various shapes, compositions, and/or shelled structures of photothermal nanoparticles may be used to select a particular heating rate for nucleic acid amplification.
- the light source 101 generates an activation light beam having a wavelength of 808 nm resonant with the resonance of the photothermal nanoparticles in the PCR tube 103 .
- the system can include a fan 109 disposed in proximity to the PCR tube 103 (e.g., the fan 109 may be disposed 1 cm away from the PCR tube 103 and the PCR tube 103 can be placed 5 cm away from the light source 101 , as illustrated in FIG. 1 A ) and can be activated to accelerate the cooling of the reaction mixture during the cooling phases of the thermocycling.
- a fan controller preferably allows a control of the activation of the fan 109 .
- a timer can time the cycles between the PCR reactions.
- FIGS. 2 A- 2 U illustrate example nanoparticles, in accordance with the present disclosure.
- the nanoparticles can be a variety of geometric shapes.
- the particular geometric shapes of the nanoparticles, as well as the chemical composition of the same, provide photothermal nanoparticles that are stable under light irradiation and have high photo-to-thermal conversion efficiency.
- the geometry of the photothermal nanoparticles are non-spherical and/or non-rod shaped.
- the nanoparticles can include shapes having four or more faces and sphere-like shapes.
- the nanoparticles have four or more faces and can be polyhedral shaped.
- the faces can be polygonal faces that are planar, convex and/or concave (e.g., diagonal faces).
- the sphere-like shapes can include less than four faces that are curved, such as a sphere, a torus or ring, and spheroids.
- the nanoparticles can be hollow, solid, or cored-shelled shaped.
- the geometry of the photothermal nanoparticles can be generally categorized in groups.
- the nanoparticles can be single component polyhedral nanoparticles.
- a single component polyhedral nanoparticle refers to or includes a nanoparticle comprised of a single material, such as platinum for example.
- a sub-group or sub-category of the single component polyhedral nanoparticle includes or refers to the shapes of the nanoparticles.
- the single component polyhedral nanoparticle can include polyhedral shapes such as cubes, prisms, octahedrons, and/or platonic shapes.
- the single component polyhedral nanoparticles can include polyhedral shapes, which are hollow, such that the nanoparticles are frames or cage-like.
- polyhedral frames or hollow polyhedrons include cubic cages, regular rings, hexagonal rings, triangular rings, among other hollow structures.
- the polyhedral nanoparticles can have multiple components (e.g., a multi-component nanoparticle).
- the nanoparticles can be comprised of a combination of metallic elements (e.g., an alloy) and/or can have a number of layers/shells.
- the nanoparticles can have a single shell surrounding a core metal (e.g., a core-shell nanoparticle) and/or can have a plurality of shell layers surrounding a core metal (e.g., multi-shell nanoparticle).
- the photothermal nanoparticle may be a multi-component polyhedral nanoparticle including a plasmonic core and more than one shell layer.
- each of the photothermal nanoparticles illustrated in FIGS. 2 A- 2 U is characterized by photothermal properties sufficient for increasing a temperature of a mixture in contact with the photothermal nanoparticle.
- the photothermal nanoparticles may be characterized by photothermal properties sufficient for increasing a temperature of the mixture from 55 degrees C. to 95 degrees C. within 1 second, for increasing the temperature of the mixture from 55 degrees C. to 95 degrees C. within 2 seconds, and/or for increasing the temperature of the mixture from 55 degrees C. to 95 degrees C. within 4 seconds.
- the photothermal nanoparticles may be characterized by photothermal properties sufficient for increasing the temperature of a mixture in contact with the photothermal nanoparticle at a rate of up to 75 degrees C. per second, at a rate of up to 40 degrees C. per second, at a rate of up to 20 degrees C. per second, and/or at a rate of up to 10 degrees C. per second.
- FIG. 2 A illustrates an example nanostar-shaped nanoparticle.
- the nanostar shape includes or refers to a three-dimensional star polygon shape, such as regular star polyhedra, having self-intersecting faces and/or self-intersecting edges.
- the nanostar shape can be a regular star polyhedra, such as a Kepler-Poinsot polyhedra, including faces that are pentagrams, triangles, or pentagons.
- the nanostar-shaped nanoparticle illustrated in FIG. 2 A includes self-intersecting triangular faces 201 .
- example nanostar shapes include a small stellated dodecahedron, a great stellated dodecahedron, a great icosahedron, and a great dodecahedron.
- Other example nanostar shapes include polyhedra such as a pentagrammic prism, a pentagrammic dipyramid, a great didecicosahedron, and a great dodecicosacron.
- the uniform star polyhedra have regular faces or regular star polygon faces.
- the dual uniform star polyhedra have regular faces or regular star polygon vertex figures.
- nanoparticles may have a nanohexapod shape.
- a nanohexapod nanoparticle refers to or includes a nanoparticle having an octahedral core and six arms grown on its vertices. Nanoparticles with a nanohexapod shape are also referred to herein as nanoparticles with a nanohexapod geometry.
- FIG. 2 B illustrates example triangular prism or triangular plate-shaped nanoparticles.
- the triangular plate-shaped or triangular prism shape includes or refers to a polyhedron having two triangular faces 203 - 1 , 203 - 2 or bases, and three faces 205 - 1 , 205 - 2 , 205 - 3 joining corresponding sides of the triangular faces (e.g., rectangular faces).
- Other embodiments can include a triangular pyramid or a tetrahedron which includes or refers to a polyhedron having four triangular faces, six straight edges, and four vertex corners.
- FIG. 2 C illustrates an example nanocube-shaped nanoparticle.
- a nanocube shape includes or refers to a polyhedron having six square faces 207 with three of the faces meeting at each vertex. As shown, the nanocube can have six faces, twelve edges, and eight vertices. While not illustrated in FIG. 2 C , the nanocube-shaped nanoparticle may be a concave nanocube such that each of the six square faces 207 has a concave surface.
- FIG. 2 D illustrates example ring-shaped nanoparticles.
- the ring shape includes a torus, e.g., a surface of revolution generated by circle or oval in three-dimensional shape above an axis coplanar with the circle or oval.
- FIG. 2 E illustrates an example nanocage-shaped nanoparticle.
- a nanocage-shaped nanoparticle is also referred to herein as a nanoparticle with a nanocage geometry.
- the nanocage shape is similar to the nanocube, with the cube being hollow (e.g., no faces).
- a nanocage shape includes or refers to a polyhedron having six square faces defined by edges. As shown, the nanocage can have twelve edges and eight vertices, which define the “faces” that are, in such embodiments, apertures. For instance, each “face” includes a square-shaped perimeter 209 which defines the boundaries of a hollow, square-shaped opening 211 , on each face.
- FIG. 2 F illustrates example triangular ring-shaped nanoparticles.
- the triangular ring shape is similar to the triangular prism or triangular plate-shaped nanoparticles with the prism being hollow.
- the triangular ring shape includes or refers to a polyhedron having three physical faces 213 - 1 , 213 - 2 , 213 - 3 (e.g., the illustrated rectangular faces) that join corresponding sides forming a triangular shape.
- the triangular shape formed by the intersecting faces 213 - 1 , 213 - 2 , and 213 - 3 define the boundaries of a hollow, triangular-shaped opening 215 .
- FIG. 2 G illustrates an example nanobar-shaped nanoparticle.
- a nanobar shape includes or refers to a polyhedron having six faces with three of the faces meeting at each vertex. At least two of the rectangular faces can be squares, while a remainder of the faces can be rectangular, although embodiments are not so limited. For instance, as illustrated in FIG. 2 G , faces 217 - 1 and 217 - 2 are rectangular, whereas faces 219 - 1 and 219 - 2 are square.
- FIG. 2 H illustrates an example octahedron-shaped nanoparticle.
- An octahedron includes or refers to a polyhedron having eight faces, twelves edges, and six vertices.
- the eight faces 221 can be triangles with four of each of the faces meeting at each vertex.
- FIG. 2 H illustrates a nanoparticle having bipyramid-shaped geometry, examples are not so limited. As illustrated, the nanoparticles described herein may have a non-bipyramid shaped geometry.
- FIG. 2 I illustrates an example icosahedron-shaped nanoparticle.
- An icosahedron shape includes or refers to a polyhedron having twenty faces, twelve vertices, and thirty edges. As shown, each of the twenty faces 223 can be triangular-shaped.
- FIG. 2 J illustrates an example tetrahexahedron-shaped nanoparticle.
- a tetrahexahedron shape includes or refers to a polyhedron having twenty-four faces 225 that are each triangular shaped, and four of each of the twenty-four faces correspond to a face of a cube.
- FIG. 2 K illustrates an example trisoctahedron-shaped nanoparticle.
- a trisoctahedron shape includes or refers to a polyhedron having twenty-four faces 227 that are each triangular shaped, and three of each corresponding to a face of an octahedron.
- FIG. 2 L illustrates an example rhombicosidodecahedron-shaped nanoparticle.
- a rhombicosidodecahedron shape includes or refers to a polyhedron having twenty triangular-shaped faces, thirty square shaped faces, twelve regular pentagonal faces, sixty vertices, and one-hundred twenty edges.
- FIG. 2 M illustrates an example decahedron-shaped nanoparticle.
- a decahedron includes or refers to a polyhedron with ten faces.
- the decahedron can be an octagonal prism, a square antiprism, a square cupola, a pentagonal bipyramid, an augmented pentagonal prims, a pentagonal trapezohedron, or an enneagonal pyramid, among others.
- the faces of the decahedron can include different geometric shapes.
- each of faces 231 - 1 and 231 - 2 can include a plurality of triangular faces 233
- each of the side faces can include a square or rectangular face 235 and a rectangular face 237 on opposing sides of the rectangular face 235 .
- a variety of the above-described shaped nanoparticles can be solid, hollow, core-shelled, or multi-shelled particles.
- a core-shelled particle includes or refers to a particle that is a composite structure having more than one concentric layer.
- a multi-core shell particle includes or refers to a core-shell particle with more than two concentric layers. Such particles can be formed by coating a nanoparticle with another kind of nanomaterial.
- FIG. 2 N illustrates example core-shell nanoprism-shaped nanoparticles.
- the core-shell nanoprism includes two nanoprisms, as described above, with one of the nanoprisms 241 being the interior, and the other 243 being formed around the interior nanoprism 241 .
- FIG. 2 O illustrates example hollow nanosphere shaped nanoparticles.
- Nanosphere shaped nanoparticles are also referred to herein as nanoparticles with a nanospherical geometry.
- a hollow nanosphere shape includes or refers to a sphere 245 that has a hollow interior (e.g., hollow core).
- FIG. 2 P illustrates example nanoparticles composed of one nanosphere core with multiple nanosphere shells.
- the nanospheres with one core and multiple shells refers to three or more nanospheres with a solid interior.
- the most inner nanosphere 247 is the core
- the second nanosphere 249 is formed around the first nanosphere 247
- the third (or more) nanosphere 251 is formed as an outer layer around the second nanosphere 249 .
- FIG. 2 Q illustrates an example rice-like-shaped nanoparticle.
- the rice-like shape includes or refers to a spheroid or a flattened sphere shape. As shown, the rice-like shapes can be elongated or prolate spheroids.
- FIG. 2 R illustrates an example hexagonal plate-shaped nanoparticle.
- the hexagonal plate shape includes or refers to a polyhedron having two hexagonal faces or bases (e.g., face 253 and an opposing hexagonal face that is not expressly illustrated or numbered in FIG. 2 R ), and six faces joining corresponding sides of the two hexagonal faces.
- the six faces joining the corresponding hexagonal faces can be rectangular faces 255 , as illustrated.
- FIGS. 2 S- 2 U illustrate example hexagonal ring-shaped nanoparticles.
- the hexagonal ring-shaped nanoparticle includes or refers to a hexagonal plate-shaped nanoparticle that has a hollow center or cavity.
- the hexagonal nanoparticle illustrated in FIG. 2 S includes a hollow center 257
- the hexagonal nanoparticle illustrated in FIG. 2 T includes a hollow center 259
- the hexagonal nanoparticle illustrated in FIG. 2 S includes a hollow center 261 .
- the hollow center or cavity can have a hexagonal shape or other shapes.
- hollow center 257 of FIG. 2 S is hexagonal shaped
- hollow center 261 of FIG. 2 U is circular shaped.
- the hollow center of each hexagonal nanoparticle can have a different diameter.
- hollow center 257 of FIG. 2 S has a diameter 258 which is greater than diameter 260 of hollow center 259 illustrated in FIG. 2 T .
- the portion of the hexagonal ring-shaped nanoparticles between the exterior of the hexagonal faces and the hollow center or cavity can be hollow or solid, in various examples.
- the portion of the hexagonal ring-shaped particle between exterior surface 262 and interior surface 263 can be hollow or solid.
- a number of specific embodiments are directed to systems and/or kits that include a plurality of the one or more above-described photothermal nanoparticles, DNA polymerase, and reaction reagent.
- the DNA polymerase is thermostable.
- the reaction reagent includes dNTPs, buffer, Mg+ (e.g., Magnesium Chloride (MgCl2)), and, optionally, a stabilizing agent.
- the components of the kit can each be provided in separate volumes (e.g., containers) and/or can be combined into one or more volume/container/mixture.
- the nanoparticles, DNA polymerase, and reaction agent can all be in one container.
- the DNA polymerase and reaction reagents are combined into a master mix and contained in a first container and the nanoparticles are in a separate container.
- the plasmonic photothermal nanoparticles can be either suspended in the solution or secured to a microfluidic chip (microchip) or surface of a plate for housing a reaction mixture.
- the PCR tube or PCR plate well can have nanoparticles as heating media described herein, PCR reaction mixture including nucleic acid template and polymerase enzyme for performance of PCR as described herein.
- the PCR reaction mixture may be formed with the heating media comprising the photothermal nanoparticles fabricated on the multi-well plate, where the photothermal nanoparticles have a nanorod geometry and are made essentially of gold.
- the nucleic acid capable of being amplified using the present invention includes, but is not limited to, DNA (single-stranded, double-stranded, linear, covalently closed, supercoiled and relaxed circular forms) or RNA (single stranded, double stranded, linear or covalently closed), or a combination of DNA and RNA.
- mixture encompasses any biological material either naturally occurring or scientifically engineered, which contains at least one nucleic acid in addition to other non-nucleic acid material, such as biomolecules (e.g., proteins, polysaccharides, lipids, low molecular weight enzyme inhibitors, oligonucleotides, primers, templates), polyacrylamide, trace metals, organic solvents, etc.
- biomolecules e.g., proteins, polysaccharides, lipids, low molecular weight enzyme inhibitors, oligonucleotides, primers, templates
- polyacrylamide e.g., polyacrylamide, trace metals, organic solvents, etc.
- trace metals e.g., organic solvents, etc.
- organic solvents e.g., etc.
- naturally-occurring mixtures include, but are not limited to, whole blood, blood plasma, and other body fluids as well as tissue cell cultures obtained from humans, plants, or animals.
- scientifically-engineered mixtures include, but are not limited to, lysates, nucleic acid samples eluted from agarose and/or polyacrylamide gels, solutions containing multiple species of nucleic acid molecules resulting either from nucleic acid amplification methods such as PCR amplification or reverse transcription polymerase chain reaction (RT-PCR) amplification or from RNA or DNA size selection procedures, and solutions resulting from post-sequencing reactions.
- nucleic acid amplification methods such as PCR amplification or reverse transcription polymerase chain reaction (RT-PCR) amplification or from RNA or DNA size selection procedures
- RT-PCR reverse transcription polymerase chain reaction
- sample generally refers to any material containing nucleic acid, including for example foods and allied products, clinical, and environmental samples.
- the sample will generally be a biological sample, which may contain any viral or cellular material, including all prokaryotic or eukaryotic cells, viruses, bacteriophages, mycoplasmas, protoplasts, and organelles.
- Such biological material may thus comprise all types of mammalian and non-mammalian animal cells, plant cells, algae including blue-green algae, fungi, bacteria, protozoa, etc.
- Representative samples thus include whole blood and blood-derived products such as plasma, serum and buffy coat, urine, feces, cerebrospinal fluid or any other body fluids, tissues, cell cultures, cell suspensions, etc.
- the sample may comprise a lysate.
- the sample may also include relatively pure starting material such as a PCR product or semi-pure preparations obtained by other nucleic acid recovery processes.
- photothermal cycles for rapid PCR were conducted with photothermal nanoparticles having different shapes and similar absorbance as described herein.
- Particular examples include photothermal cycles using different photothermal nanoparticles: gold nanostars (e.g., gold nanostars coated with polyethylene glycol (PEG)) and silver nanoprisms (e.g., silver triangular nanoplates).
- gold nanostars e.g., gold nanostars coated with polyethylene glycol (PEG)
- silver nanoprisms e.g., silver triangular nanoplates
- FIG. 3 A illustrates photothermal cycles of silver nanoprisms coated with polyvinylpyrrolidone in accordance with the present disclosure.
- FIG. 3 C illustrates photothermal cycles of gold nanostars coated with polyethylene glycol in accordance with the present disclosure.
- photothermal nanoparticles in GoTaq® G2 Hot Start PCR Mastermix solutions (2 optical density (O.D), 25 uL) were irradiated with 2 W/cm2 laser and photothermal cycles were recorded over 15 minutes, and then the respective solutions irradiated continuously to test the nanoparticle degradation at 95 degrees C.
- the silver nanoprisms demonstrated an average heating rate (from 45 degrees C.
- FIG. 3 B illustrates an example transmission electron microscope (TEM) image of silver nanoprisms in accordance with the present disclosure.
- FIG. 3 C illustrates example photothermal cycles of gold nanostars coated with polyethylene glycol in accordance with the present disclosure.
- the gold nanostars coated with PEG demonstrated an average heating rate (from 45 degrees C. to 95 degrees C.) of 31.7 seconds, and an average cooling rate (from 95 degrees C. to 45 degrees C.) of 45.3 seconds.
- FIG. 3 D illustrates an example TEM image of gold nanostars in accordance with the present disclosure.
- FIG. 3 E illustrates example photothermal cycles of gold nanocages coated with polyethylene glycol in accordance with the present disclosure.
- the gold nanocages coated with PEG demonstrated an average heating rate (from 45 degrees C. to 95 degrees C.) of 2.5 seconds, and an average cooling rate (from 95 degrees C. to 45 degrees C.) of 17 seconds.
- different concentrations of photothermal nanoparticles (0-50 O.D), laser power, or various volumes of PCR mastermix solutions (5-50 uL) can be used.
- FIG. 3 F illustrates an example TEM image of gold nanocages in accordance with the present disclosure.
- FIG. 3 G illustrates an example ultraviolet-visible spectrum showing the maximum light absorbance peak of gold nanostars and silver nanoprisms in accordance with the present disclosure.
- the silver nanoprisms demonstrated absorbance intensity of 1.897 A.U.s at a peak wavelength of 726 nm.
- the gold nanostars demonstrated absorbance intensity of 1.975 A.U.s at a peak wavelength of 798 nm.
- FIGS. 4 A, and 4 B illustrate gel electrophoresis results from rapid nucleic acid amplification inhibition using photothermal nanocages in accordance with the present disclosure.
- PCR was performed using a cDNA template made with dT primer and RTX Exo+GoTaq® G2 Hot Start Mastermix. 200 nM of two different primers were used, beta 1 microglobulin (B2M) primers (on the left of FIG. 4 B ) and guanine nucleotide-binding protein subunit beta-2-like 1 (GNB2L1) primers (on the right of FIG. 4 B ).
- B2M beta 1 microglobulin
- GNB2L1 guanine nucleotide-binding protein subunit beta-2-like 1
- Gold nanocages coated with PEG were added to the reaction mixture in concentrations from 0 to 16 O.D.
- the total reaction mixture volume was 25 ⁇ L.
- the solution was heated for 2 minutes at 95 degrees C., and then cycled according to the following pattern 35 times: 30 seconds at 95 degrees C., 30 seconds at 60 degrees C., and 30 seconds at 72 degrees C.
- FIG. 4 B consistent results were achieved at each of the nanoparticle concentrations used during PCR indicating that there was no significant PCR inhibition observed as a result of adding the gold nanocages to the PCR reaction mixture.
- FIG. 5 illustrates gel electrophoresis results from rapid nucleic acid amplification using photothermal nanocages in accordance with the present disclosure.
- a reaction mixture consisting of non-hot start recombinant Taq DNA polymerase, a PCR nucleotide mixture (Deoxyadenosine triphosphate (dATP), Deoxycytidine triphosphate (dCTP), Deoxyguanosine triphosphate (dGTP) and Deoxythymidine triphosphate (dTTP)), a forward and reverse primer, a PCR buffer, 50 ng of human genomic DNA, and 2 O.D of PEGylated gold nanocages was prepared on ice.
- dATP Deoxyadenosine triphosphate
- dCTP Deoxycytidine triphosphate
- dGTP Deoxyguanosine triphosphate
- dTTP Deoxythymidine triphosphate
- the PCR primers were designed to amplify a 337 base pair portion of the Human Beta-globin gene.
- 20 ⁇ l of the reaction mixture was added to a 0.2 ml PCR tube and overlaid with 15 ⁇ l of mineral oil and left on ice.
- a 2-step photonic PCR cycling was performed in a prototype instrument. 35 cycles were performed as follows: temperature 1 (T1) was set at approximately 94° C. and temperature 2 (T2) was set at approximately 64° C. Both temperatures were previously confirmed with a thermocouple probe placed in the reaction mix and cycling with the laser at 70%. To achieve T1, the laser was active/on and excited the nanoparticles and heated them, which in turn heats the reaction mix.
- the temperature was measured using an infrared (IR) sensor, and after the reaction mix reached the proper temperature, the laser was turned off, and a fan activated to cool the reaction mixture to the proper temperature that then activated the laser, thus initiating another cycle.
- IR infrared
- Three different T1 reaction temperatures were tested in 3 separate reaction tubes corresponding to 94° C. (well 1), 90° C. (well 2), and 86° C. (well 3). The amplifications were done in less than 15 minutes.
- a control reaction was performed by placing a reaction tube in a traditional Peltier thermocycler and cycled for 35 cycles each consisting of a 2 second denaturation step at 95° C. and an annealing step of 6 seconds at 65° C.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Toxicology (AREA)
- Nanotechnology (AREA)
Abstract
Description
Claims (13)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/880,917 US12227781B2 (en) | 2019-05-22 | 2020-05-21 | Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles |
| US19/055,103 US20250215473A1 (en) | 2019-05-22 | 2025-02-17 | Photothermal nanoparticles, devices, and kits |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851403P | 2019-05-22 | 2019-05-22 | |
| US16/880,917 US12227781B2 (en) | 2019-05-22 | 2020-05-21 | Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US19/055,103 Division US20250215473A1 (en) | 2019-05-22 | 2025-02-17 | Photothermal nanoparticles, devices, and kits |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20200370083A1 US20200370083A1 (en) | 2020-11-26 |
| US12227781B2 true US12227781B2 (en) | 2025-02-18 |
Family
ID=73457455
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/880,917 Active 2042-04-05 US12227781B2 (en) | 2019-05-22 | 2020-05-21 | Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles |
| US19/055,103 Pending US20250215473A1 (en) | 2019-05-22 | 2025-02-17 | Photothermal nanoparticles, devices, and kits |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US19/055,103 Pending US20250215473A1 (en) | 2019-05-22 | 2025-02-17 | Photothermal nanoparticles, devices, and kits |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US12227781B2 (en) |
| EP (1) | EP3972571A4 (en) |
| JP (1) | JP2022534044A (en) |
| WO (1) | WO2020237017A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112658276B (en) * | 2020-12-04 | 2023-04-07 | 东南大学 | Heterogeneous precious metal sea urchin type nanocrystal, two-dimensional superlattice film thereof, and preparation method and application thereof |
| CN112974832B (en) * | 2021-04-07 | 2023-06-20 | 南京师范大学 | A kind of preparation method of Pt concave cubic nanocrystal and its nanocrystal and application |
| TWI844051B (en) * | 2021-07-08 | 2024-06-01 | 安盛生科股份有限公司 | System, method and non-transitory computer readable medium to perform quantitative polymerase chain reaction |
| CN114062316B (en) * | 2021-11-17 | 2024-04-19 | 西北工业大学 | High-quality optical refractive index sensor based on plasmon nanometer cavity |
| WO2023128300A1 (en) * | 2021-12-29 | 2023-07-06 | 연세대학교 산학협력단 | Cartridge-type biomarker molecular diagnostic device |
| KR20240135207A (en) * | 2023-03-03 | 2024-09-10 | 한국광기술원 | Gene amplification testing device and testing method using the same |
| DE102024205214A1 (en) * | 2024-06-06 | 2025-12-11 | Robert Bosch Gesellschaft mit beschränkter Haftung | Nucleic acid amplification system |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120046593A1 (en) | 2005-01-22 | 2012-02-23 | Alexander Oraevsky | Laser activated nanothermolysis of cells |
| US20140170664A1 (en) | 2012-12-14 | 2014-06-19 | The Royal Institution For The Advancement Of Learning/Mcgill University | Heating mechanism for dna amplification, extraction or sterilization using photo-thermal nanoparticles |
| US20160076086A1 (en) | 2013-03-22 | 2016-03-17 | Duke University | Nano-plasmonic molecular probes and methods of use |
| WO2016115542A1 (en) | 2015-01-16 | 2016-07-21 | The Regents Of The University Of California | Led driven plasmonic heating apparatus for nucleic acids amplification |
| WO2016200525A1 (en) * | 2015-06-08 | 2016-12-15 | The University Of Chicago | Bipyramid-templated synthesis of monodisperse noble metal nanocrystals |
| US20170000547A1 (en) | 2010-08-27 | 2017-01-05 | Sienna Biopharmaceuticals, Inc. | Compositions and methods for thermal skin treatment with metal nanoparticles |
| US20180193910A1 (en) | 2015-07-01 | 2018-07-12 | Memorial Sloan Kettering Cancer Center | Anisotropic particles, methods and uses thereof |
-
2020
- 2020-05-21 JP JP2021569426A patent/JP2022534044A/en active Pending
- 2020-05-21 WO PCT/US2020/033940 patent/WO2020237017A1/en not_active Ceased
- 2020-05-21 EP EP20810328.3A patent/EP3972571A4/en active Pending
- 2020-05-21 US US16/880,917 patent/US12227781B2/en active Active
-
2025
- 2025-02-17 US US19/055,103 patent/US20250215473A1/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120046593A1 (en) | 2005-01-22 | 2012-02-23 | Alexander Oraevsky | Laser activated nanothermolysis of cells |
| US20170000547A1 (en) | 2010-08-27 | 2017-01-05 | Sienna Biopharmaceuticals, Inc. | Compositions and methods for thermal skin treatment with metal nanoparticles |
| US20140170664A1 (en) | 2012-12-14 | 2014-06-19 | The Royal Institution For The Advancement Of Learning/Mcgill University | Heating mechanism for dna amplification, extraction or sterilization using photo-thermal nanoparticles |
| US20160076086A1 (en) | 2013-03-22 | 2016-03-17 | Duke University | Nano-plasmonic molecular probes and methods of use |
| WO2016115542A1 (en) | 2015-01-16 | 2016-07-21 | The Regents Of The University Of California | Led driven plasmonic heating apparatus for nucleic acids amplification |
| US20180080064A1 (en) | 2015-01-16 | 2018-03-22 | The Regents Of The University Of California | Led driven plasmonic heating apparatus for nucleic acids amplification |
| WO2016200525A1 (en) * | 2015-06-08 | 2016-12-15 | The University Of Chicago | Bipyramid-templated synthesis of monodisperse noble metal nanocrystals |
| US20180193910A1 (en) | 2015-07-01 | 2018-07-12 | Memorial Sloan Kettering Cancer Center | Anisotropic particles, methods and uses thereof |
Non-Patent Citations (8)
| Title |
|---|
| Hiroaki Agawa et al., Photothermal Conversion Using Localized Surface Plasmon Resonance, Journal of the Japan Society of Colour Material, vol. 90, No. 12, pp. 414-419 (2017), (English Abstract). |
| Kim et al, Plasmonic Photothermal Nanoparticles for Biomedical Applications, 2019, Adv.Sci., 6, pp. 1-23 (Year: 2019). * |
| Lee et al, Plasmonic Photothermal Gold Bipyramid Nanoreactors for Ultrafast Real-Time Bioassays, 2017, J. Am. Chem. Soc. 2017, 139, 8054-8057, Published May 1, 2017. (Year: 2017). * |
| Lee et al, Plasmonic Photothermal Gold Bipyramid Nanoreactors for Ultrafast Real-Time Bioassays, 2017, J. Am. Chem. Soc. 2017, 139, 8054-8057, supporting information s1-s16. (Year: 2017). * |
| Roche et al. "Demonstration of a Plasmonic Thermocycler for the Amplification of Human Androgen Receptor DNA," Analyst, Jul. 17, 2012 (Jul. 17, 2012), vol. 137, pp. 4475-4481, entire document. |
| Shamraiz, et al , Gold nanotubes and nanorings: promising candidates for multidisciplinary fields, International Materials Reviews, 2018, pp. 1-35. (Year: 2018). * |
| Wang et al , Understanding the photothermal effect of gold nanostars and nanorods for biomedical applications, RSC Adv., 2014, 4, 30375-30383. (Year: 2014). * |
| Yukina Takahashi et al., Photoenergy Conversion Systems by Utilizing Localized Surface Plasmon Resonance Based on Metal Nanostructures, Journal of the Japan Society of Colour Material, vol. 90, No. 12, pp. 426-430 (2017), (English Abstract). |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3972571A4 (en) | 2023-12-06 |
| US20250215473A1 (en) | 2025-07-03 |
| US20200370083A1 (en) | 2020-11-26 |
| JP2022534044A (en) | 2022-07-27 |
| EP3972571A1 (en) | 2022-03-30 |
| WO2020237017A1 (en) | 2020-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250215473A1 (en) | Photothermal nanoparticles, devices, and kits | |
| JP4477089B2 (en) | Nucleic acid sequence amplification method and apparatus using thermal convection | |
| ES2596452T3 (en) | Nucleic Acid Amplification Method | |
| US20200181604A1 (en) | Protein arrays and methods of using and making the same | |
| CN108367287B (en) | extreme reverse transcription PCR | |
| EP3066222B1 (en) | Induction pcr | |
| US7927797B2 (en) | Nucleic acid amplification with continuous flow emulsion | |
| JP7104048B2 (en) | Hydrophilic coating of fluid channels | |
| EP2565650A1 (en) | Device and method for manipulating droplets using gel-state medium | |
| CN102146373A (en) | Nucleic acid amplification method, nucleic acid amplification apparatus, and chip used in nucleic acid amplification | |
| JP2018515140A (en) | Reaction tube for nucleic acid amplification capable of controlling liquid circulation path | |
| US20160244810A1 (en) | Method for steadying thermal convection flow field in solution during thermal convective polymerase chain reaction | |
| KR101830778B1 (en) | Device and method for amplifying nucleic acid using oil layer comprising heating particles | |
| JPWO2020096015A1 (en) | A method for detecting genome-related information of cells coexisting with one or more test substances | |
| CN113493818A (en) | Method for amplifying nucleic acid in single cell | |
| JPWO2020237017A5 (en) | ||
| TrucáPhuong et al. | Potential of gold nanoparticles in nucleic acid amplification: From amplification enhancement to product detection | |
| US20230131184A1 (en) | Intermittent warming of a biologic sample including a nucleic acid | |
| Atkin | PET biochip fabrication for DNA sample preparation | |
| HK1109425B (en) | Method and apparatus for amplification of nucleic acid sequences by using thermal convection | |
| CN111356771A (en) | Particles to which UCST material is applied and nucleic acid amplification method using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| AS | Assignment |
Owner name: PROMEGA CORPORATION, WISCONSIN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZENG, ZHIYANG;CORONA, CESEAR;ZHOU, WENHUI;AND OTHERS;SIGNING DATES FROM 20200512 TO 20200521;REEL/FRAME:052731/0307 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |